Lanzl I - Search Results

1

[Adherence to anti-VEGF treatment-Considerations and practical recommendations].

Lommatzsch A, Eter N, Ehlken C, Lanzl I, Kaymak H, Schuster AK, Ziemssen F. Lommatzsch A, et al. Among authors: lanzl i. Ophthalmologe. 2021 Aug;118(8):801-809. doi: 10.1007/s00347-020-01273-5. Epub 2020 Dec 3. Ophthalmologe. 2021. PMID: 33270147 Free PMC article. Review. German.

2

Systematic review: non-adherence and non-persistence in intravitreal treatment.

Ehlken C, Ziemssen F, Eter N, Lanzl I, Kaymak H, Lommatzsch A, Schuster AK. Ehlken C, et al. Among authors: lanzl i. Graefes Arch Clin Exp Ophthalmol. 2020 Oct;258(10):2077-2090. doi: 10.1007/s00417-020-04798-2. Epub 2020 Jun 22. Graefes Arch Clin Exp Ophthalmol. 2020. PMID: 32572607 Free PMC article. Review.

3

[Retinochoroidopathy after intravitreal anti-VEGF treatment].

Maier M, Feucht N, Lanzl I, Kook P, Lohmann CP. Maier M, et al. Among authors: lanzl i. Ophthalmologe. 2009 Aug;106(8):729-34. doi: 10.1007/s00347-008-1839-3. Ophthalmologe. 2009. PMID: 18953546 German.

4

[Loss of vision after intravitreal dexamethasone injection in a vitrectomized eye].

Reitmeier V, Kern C, Poimenidou M, Lanzl IM. Reitmeier V, et al. Among authors: lanzl im. Ophthalmologe. 2021 Oct;118(10):1051-1053. doi: 10.1007/s00347-021-01328-1. Epub 2021 Mar 12. Ophthalmologe. 2021. PMID: 33712902 Free PMC article. German. No abstract available.

5

[Can Anti-VEGF Injections Cause Glaucoma or Ocular Hypertension?].

Lanzl I, Kotliar K. Lanzl I, et al. Klin Monbl Augenheilkd. 2017 Feb;234(2):191-193. doi: 10.1055/s-0043-101819. Epub 2017 Feb 22. Klin Monbl Augenheilkd. 2017. PMID: 28226388 Review. German.

6

[Possibilities, limitations, and perspectives in diagnosis and treatment of glaucoma : Tried and tested procedures in a new light].

Lanzl IM. Lanzl IM. Ophthalmologe. 2016 Oct;113(10):814-815. doi: 10.1007/s00347-016-0342-5. Ophthalmologe. 2016. PMID: 27507576 German. No abstract available.

7

[Massive bilateral eye pain - Unusual case in times of the coronavirus pandemic].

Röper K, Lohmann CP, Lanzl I. Röper K, et al. Among authors: lanzl i. Ophthalmologe. 2020 Oct;117(10):1041-1044. doi: 10.1007/s00347-020-01201-7. Ophthalmologe. 2020. PMID: 32705326 Free PMC article. German. No abstract available.

8

[Possibilities and limitations of eye drops for glaucoma therapy].

Lanzl IM, Poimenidou M, Spaeth GL. Lanzl IM, et al. Ophthalmologe. 2016 Oct;113(10):824-832. doi: 10.1007/s00347-016-0332-7. Ophthalmologe. 2016. PMID: 27604586 Review. German.

9

[Possibilities and limitations of glaucoma surgery].

Reznicek L, Boghos Y, Lanzl IM. Reznicek L, et al. Among authors: lanzl im. Ophthalmologe. 2016 Oct;113(10):833-837. doi: 10.1007/s00347-016-0333-6. Ophthalmologe. 2016. PMID: 27448219 Review. German.

10

[Preservative-containing eye drops and adherence in ophthalmological practice].

Lanzl I, Kaercher T. Lanzl I, et al. Ophthalmologe. 2012 Nov;109(11):1087-92. doi: 10.1007/s00347-012-2641-9. Ophthalmologe. 2012. PMID: 23179814 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

107 results

Search Page